These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11345677)

  • 1. Federal law and syringe prescription and dispensing.
    Abrahamson D
    Health Matrix Clevel; 2001; 11(1):65-71. PubMed ID: 11345677
    [No Abstract]   [Full Text] [Related]  

  • 2. Harm reduction in the health care system: the legality of prescribing and dispensing syringes to drug users.
    Burris S; Lurie P; Ng M
    Health Matrix Clevel; 2001; 11(1):5-64. PubMed ID: 11345676
    [No Abstract]   [Full Text] [Related]  

  • 3. The genesis of syringe prescription to prevent HIV in Rhode Island.
    Rich JD; McKenzie M; Macalino G; Runnarsdottir V; Gaydos M; Mehrotra M; Stein J; Whitlock T; Salas C; Burris S
    Health Matrix Clevel; 2001; 11(1):129-45. PubMed ID: 11345673
    [No Abstract]   [Full Text] [Related]  

  • 4. An analysis of ethical issues in prescribing and dispensing syringes to injection drug users.
    Lazzarini Z
    Health Matrix Clevel; 2001; 11(1):85-128. PubMed ID: 11345679
    [No Abstract]   [Full Text] [Related]  

  • 5. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In New York City, syringe laws and regulations deter physicians and pharmacists from prescribing and selling syringes to persons who may be injection drug users.
    Lazzarini Z; Schoenbaum EE; O'Neill CH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S141-3. PubMed ID: 9663639
    [No Abstract]   [Full Text] [Related]  

  • 7. A syringe prescription program to prevent infectious disease and improve health of injection drug users.
    Rich JD; McKenzie M; Macalino GE; Taylor LE; Sanford-Colby S; Wolf F; McNamara S; Mehrotra M; Stein MD
    J Urban Health; 2004 Mar; 81(1):122-34. PubMed ID: 15047791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug use and harm reduction policy: alternative perspectives on the California proposal.
    Stauffer L
    J Health Soc Policy; 2004; 19(3):19-36. PubMed ID: 15829451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.
    Linas BP; Coffin PO; Backes G; Vlahov D
    J Urban Health; 2000 Dec; 77(4):768-80. PubMed ID: 11194316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemics of injecting drug use and blood-borne disease: a public health perspective.
    Gostin LO
    Spec Law Dig Health Care Law; 1998 Jun; (231):9-40. PubMed ID: 10181048
    [No Abstract]   [Full Text] [Related]  

  • 11. Syringe access for the prevention of blood borne infections among injection drug users.
    Stancliff S; Agins B; Rich JD; Burris S
    BMC Public Health; 2003 Nov; 3():37. PubMed ID: 14633286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993.
    Valleroy LA; Weinstein B; Jones TS; Groseclose SL; Rolfs RT; Kassler WJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):73-81. PubMed ID: 7648288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal.
    Jones TS; Coffin PO
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S6-9. PubMed ID: 12489602
    [No Abstract]   [Full Text] [Related]  

  • 14. Maine removed criminal penalties for syringe possession in 1997 after allowing sale of syringes without a prescription in 1993.
    Beckett GA; Galena R; Shields D; Mills DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S145-6. PubMed ID: 9663642
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings.
    Deren S; Cleland CM; Fuller C; Kang SY; Des Jarlais DC; Vlahov D
    AIDS Behav; 2006 Nov; 10(6):717-21. PubMed ID: 16642418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal injections: the law, science, and politics of syringe access for injection drug users.
    Burris S; Strathdee SA; Vernick JS
    Univ San Francisco Law Rev; 2003; 37(4):813-85. PubMed ID: 15457636
    [No Abstract]   [Full Text] [Related]  

  • 17. Deregulation of syringe sale and possession in New Hampshire, 1991-2000.
    Kassler W; Ayotte D
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S19-20. PubMed ID: 12489605
    [No Abstract]   [Full Text] [Related]  

  • 18. Dispensing forged prescriptions.
    Brahams D
    Lancet; 1988 Apr; 1(8589):837-8. PubMed ID: 2895361
    [No Abstract]   [Full Text] [Related]  

  • 19. Increasing legal and regulatory support for pharmacy syringe sales to injection drug users, Washington State, 1999-2002.
    Williams DH
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S23-4. PubMed ID: 12489607
    [No Abstract]   [Full Text] [Related]  

  • 20. Allowing central fill pharmacies and retail pharmacies to fill prescriptions for controlled substances on behalf of retail pharmacies. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Jun; 68(121):37405-11. PubMed ID: 12836645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.